• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.26 Up 0.10(1.62%) May 22, 4:00PM EDT
    |After Hours : 6.26 0.00 (0.00%) May 22, 4:25PM EDT
    Add to Portfolio
    Prev Close:6.16
    Open:6.18
    Bid:5.50 x 100
    Ask:6.30 x 500
    1y Target Est:8.88
    Beta:2.93
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:6.12 - 6.30
    52wk Range:4.95 - 17.42
    Volume:658,537
    Avg Vol (3m):1,583,340
    Market Cap:343.00M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRUp 1.62%343.00M
    PENCUp 0.95%22.77M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,117.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.64
    Quarterly EPS Est (Jun-15) :-0.38
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-0.51

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback